Literature DB >> 31032093

Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies.

Gianluca Tomasello1, Michele Ghidini1, Antonio Costanzo2, Antonio Ghidini3, Alessandro Russo2, Sandro Barni4, Rodolfo Passalacqua1, Fausto Petrelli4.   

Abstract

BACKGROUND: Even when resectable pancreatic cancer (PC) is associated with a dismal prognosis. Initial presentation varies according with primary tumor location. Aim of this systematic review and meta-analysis was to evaluate the prognosis associated with site (head versus body/tail) in patients with PC.
METHODS: We searched PubMed, Cochrane Library, SCOPUS, Web of Science, EMBASE, Google Scholar, LILACS, and CINAHL databases from inception to March 2018. Studies reporting information on the independent prognostic role of site in PC and comparing overall survival (OS) in head versus body/tail tumors were selected. Data were aggregated using hazard ratios (HRs) for OS of head versus body/tail PC according to fixed- or random-effect model.
RESULTS: A total of 93 studies including 254,429 patients were identified. Long-term prognosis of head was better than body/tail cancers (HR =0.96, 95% CI: 0.92-0.99; P=0.02). A pooled HR of 0.95 (95% CI: 0.92-0.99, P=0.02) from multivariate analysis only (n=77 publications) showed that head site was an independent prognostic factor for survival.
CONCLUSIONS: Primary tumor location in the head of the pancreas at the time of diagnosis is a predictor of better survival. Such indicator should be acknowledged when designing future studies, in particular in the operable and neoadjuvant setting.

Entities:  

Keywords:  Pancreatic cancer (PC); head; meta-analysis; survival; tail

Year:  2019        PMID: 31032093      PMCID: PMC6465486          DOI: 10.21037/jgo.2018.12.08

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  110 in total

1.  Pancreatic cancer in the general population: Improvements in survival over the last decade.

Authors:  Taylor S Riall; William H Nealon; James S Goodwin; Dong Zhang; Yong-Fang Kuo; Courtney M Townsend; Jean L Freeman
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

2.  Predicting survival after surgical resection for pancreatic ductal adenocarcinoma.

Authors:  Hyoun Jong Moon; Ji Yeong An; Jin Seok Heo; Seong Ho Choi; Jae Won Joh; Yong Il Kim
Journal:  Pancreas       Date:  2006-01       Impact factor: 3.327

3.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

Review 4.  Vagaries of clinical presentation of pancreatic and biliary tract cancer.

Authors:  I Modolell; L Guarner; J R Malagelada
Journal:  Ann Oncol       Date:  1999       Impact factor: 32.976

5.  Prognostic factors for survival in pancreatic cancer: a population-based study.

Authors:  Mohamad A Eloubeidi; Renee A Desmond; C Mel Wilcox; Reda J Wilson; Pavan Manchikalapati; Mona M Fouad; Isam Eltoum; Selwyn M Vickers
Journal:  Am J Surg       Date:  2006-09       Impact factor: 2.565

6.  Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine.

Authors:  Akira Sawaki; Yukihide Kanemitsu; Nobumasa Mizuno; Kuniyuki Takahashi; Tsuneya Nakamura; Tatsuya Ioka; Sachiko Tanaka; Akihiko Nakaizumi; Ahmed As Salem; Ryuzo Ueda; Kenji Yamao
Journal:  J Gastroenterol Hepatol       Date:  2008-08       Impact factor: 4.029

7.  A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.

Authors:  Tomoo Kosuge; Takahiro Kiuchi; Kiyoshi Mukai; Tadao Kakizoe
Journal:  Jpn J Clin Oncol       Date:  2006-02-20       Impact factor: 3.019

8.  Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer.

Authors:  Bunzo Nakata; Shinya Fukunaga; Eiji Noda; Ryosuke Amano; Nobuya Yamada; Kosei Hirakawa
Journal:  Oncology       Date:  2008-06-11       Impact factor: 2.935

9.  Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: a series of 308 cases.

Authors:  Apar Kishor Ganti; Anil Potti; Michael Koch; Ketki Tendulkar; David Hanekom; Vijay Koka; Ralph Levitt
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

10.  Onset symptoms and tumor locations as prognostic factors of pancreatic cancer.

Authors:  Ichiro Watanabe; Satoshi Sasaki; Masaru Konishi; Toshio Nakagohri; Kazuto Inoue; Tatsuya Oda; Taira Kinoshita
Journal:  Pancreas       Date:  2004-03       Impact factor: 3.327

View more
  12 in total

1.  Impact of the transection plan on postoperative pancreatic fistulas occurring after robot-assisted distal pancreatectomy for nonmalignant pancreatic neoplasms.

Authors:  Lihan Qian; Binwei Hu; Jiancheng Wang; Xiongxiong Lu; Xiaxing Deng; Weimin Chai; Zhiwei Xu; Weishen Wang; Baiyong Shen
Journal:  Surg Endosc       Date:  2022-08-08       Impact factor: 3.453

2.  Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Takashi Suzuki; Shozo Mori; Takayuki Shimizu; Kazuma Tago; Nobuhiro Harada; Kyung-Hwa Park; Yuhki Sakuraoka; Takayuki Shiraki; Yukihiro Iso; Taku Aoki; Keiichi Kubota
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

3.  Accuracy of an administrative database for pancreatic cancer by international classification of disease 10th codes: A retrospective large-cohort study.

Authors:  Young-Jae Hwang; Seon Mee Park; Soomin Ahn; Jong-Chan Lee; Young Soo Park; Nayoung Kim
Journal:  World J Gastroenterol       Date:  2019-10-07       Impact factor: 5.742

4.  Neoadjuvant and Adjuvant Therapy in Operable Pancreatic Cancer: Both Honey and Milk (but No Bread?).

Authors:  Kjetil Søreide
Journal:  Oncol Ther       Date:  2021-01-13

5.  Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution.

Authors:  Qi Li; Zijian Feng; Ruyi Miao; Xun Liu; Chenxi Liu; Zhen Liu
Journal:  World J Surg Oncol       Date:  2022-01-07       Impact factor: 2.754

6.  Liquid biopsy reveals collateral tissue damage in cancer.

Authors:  Asael Lubotzky; Hai Zemmour; Daniel Neiman; Marc Gotkine; Netanel Loyfer; Sheina Piyanzin; Bracha-Lea Ochana; Roni Lehmann-Werman; Daniel Cohen; Joshua Moss; Judith Magenheim; Maureen F Loftus; Lauren Brais; Kimmie Ng; Raul Mostoslavsky; Brian M Wolpin; Aviad Zick; Myriam Maoz; Albert Grinshpun; Anatoli Kustanovich; Chen Makranz; Jonathan E Cohen; Tamar Peretz; Ayala Hubert; Mark Temper; Azzam Salah; Shani Avniel-Polak; Simona Grozinsky-Glasberg; Kirsty L Spalding; Ariel Rokach; Tommy Kaplan; Benjamin Glaser; Ruth Shemer; Yuval Dor
Journal:  JCI Insight       Date:  2022-01-25

7.  Late metachronous cerebral metastasis of pancreatic adenocarcinoma of the tail of the pancreas: a case report.

Authors:  Kyriakos Papadimitriou; Daniel Kiss-Bodolay; Abderrahmane Hedjoudje; Diego San Millan; Alexandre Simonin; Jean-Yves Fournier; Karen Huscher
Journal:  J Med Case Rep       Date:  2022-04-04

8.  Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.

Authors:  Yu-Feng Li; Yu-Cheng Xiang; Qiu-Qiang Zhang; Wei-Lin Wang
Journal:  J Gastrointest Oncol       Date:  2020-08

9.  Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.

Authors:  Wenjing Song; Xin He; Pengju Gong; Yan Yang; Sirui Huang; Yifan Zeng; Lei Wei; Jingwei Zhang
Journal:  Front Genet       Date:  2021-06-23       Impact factor: 4.599

10.  Resected pancreatic adenocarcinoma: An Asian institution's experience.

Authors:  Kennedy Yao Yi Ng; Edwin Wei Xiang Chow; Bochao Jiang; Cindy Lim; Brian Kim Poh Goh; Ser Yee Lee; Jin Yao Teo; Damien Meng Yew Tan; Peng Chung Cheow; London Lucien Peng Jin Ooi; Pierce Kah Hoe Chow; Joycelyn Jie Xin Lee; Juinn Huar Kam; Ye Xin Koh; Prema Raj Jeyaraj; Ek Khoon Tan; Su Pin Choo; Chung Yip Chan; Alexander Yaw Fui Chung; David Tai
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.